AstraZeneca, Sputnik V vaccines to be combined in one medicine

Source : 112 Ukraine

The volunteers over the age of 18 will participate in the trials
17:15, 11 December 2020


AstraZeneca will start the clinical trials to test a combination of its vaccine with the Russian Sputnik V as Bloomberg reported.

“Combinations of different COVID-19 vaccines may be an important step in generating wider protection through a stronger immune response and better accessibility,” the company reported.

The volunteers over the age of 18 will participate in the trials. It is specified that they will start until the end of 2020. The vaccine might be used if its efficacy will make over 90%. Meanwhile, AstraZeneca vaccine has 70% efficiency, while the Russian one stated to be more than 90%.

Related: Ukrainian medics, military, law enforcers to get vaccine first, - official

It is specified that both AZD1222 and Sputnik V are adenoviral vector vaccines that contain genetic material of SARS-CoV-2 virus spike protein. The adenovirus itself is unable to replicate so it can only act as a carrier of genetic material.

As we reported, as tests of various vaccine manufacturers are underway, American company Moderna, Inc. decided to shape the test group from teenagers aged from 12 to 18 years old.

Related: Bill Gates Foundation: It is too late for fair distribution of vaccines against Covid-19

Earlier, the UK approved the use of the Pfizer vaccine against coronavirus in the country. Britain has ordered 40 million doses of Pfizer vaccine for the vaccination of 20 million of the population. Soon, about 10 million doses will be supplied to the country, while the first 800,000 doses will arrive in the country in the next few days.



Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more